25. Biasucci LM. CDC/AHA workshop on markers of risk in diabetic and non-diabetic patients. J Clin Endocrinol inflammation and cardiovascular disease. Application Metab 2005;90:5698-5703. to clinical and public health practice. Clinical use of 44. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes inflammatory markers in patients with cardiovascular Association; European Association for the Study of Diabetes. diseases. Circulation 2004;110:e560-e567. Joint Statement from the American Diabetes Association

26. Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R. and the European Association for the Study of Diabetes.

Cardiovascular disease in U.S. patients with metabolic The metabolic syndrome: time for a critical appraisal. syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 2005;28:2289-2304.

Diabetes Care 2005;28:690-693. 45. American Diabetes Association. Diagnosis and classification
27. Noack B, Genco RJ, Trevisan M, Grossi SG, Zambon of diabetes mellitus. Position statement. Diabetes Care
JJ, De Nardin E. Periodontal infections contribute to 2005; 29(suppl1):s37-s42.
elevated systemic C-reactive protein level. J Periodontol 46. DECODE Study Group. Glucose tolerance and mortality:
2001;72:1221-1227. comparison of WHO and American Diabetes Association
28. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos diagnostic criteria. European Diabetes Epidemiology
CT. Examination of the relation between periodontal health Group. Diabetes Epidemiology: Collaborative analysis of
status and cardiovascular risk factors: Serum total and diagnostic criteria in Europe. Lancet 1999;354:617-621.
high density lipoprotein, cholesterol, C-reactive protein, 47. Genco RJ, Grossi SG, Ho A, Nishimura F, Muayama Y. A
and plasma fibrinogen. Am J Epidemiol 2000;151:273- proposed model linking inflammation to obesity, diabetes
282. and periodontal infection. J Periodontol 2005;76:2075-

29. D’Aiuto F, Parkar M, Andreou G, et al. Periodontitis and 2084. systemic inflammation: control of the local infection 48. Genco R, Offenbacher S, Beck J. Periodontal disease is associated with a reduction in serum inflammatory and cardiovascular disease: epidemiology and possible markers. J Dent Res 2004;83:156-16.0 mechanisms. J Am Dent Assoc 2002;133(suppl):s14-s22.

30. Mealey BL. Diabetes mellitus. In Rose LF, Genco RJ, Mealey 49. Scannapieco FA, Bush RB, Paju S. Associations between BL, Cohen DW, editors: Periodontal Medicine,Toronto 2000, periodontal disease and risk for atherosclerosis, BC Decker Publishers.. cardiovascular disease and stroke. A systematic review.

31. Laakso M, Pyorala K. Age at onset and type of diabetes. Ann Periodontol 2003;8:38-53.

Diabetes Care 1985;8:114-117. 50. Janket S-J, Baird AE, Chuang S-K, Jones JA. Meta-analysis

32. Drobny EC, Abramson EC, Bauman G. Insulin receptors of periodontal disease and risk for coronary heart disease in acute infection: A study of factors conferring insulin and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol, resistance. J Clin Endocrinol Metab 1984;58:710-716. Endod 2003;95:559-569.

33. Sammalkorpi K. Glucose intolerance in acute infections. J 51. Williams RC Jr, Mahan CJ. Periodontal disease and diabetes Intern Med 1989;225: 15-19. in young adults. JAMA 1960;172:776-778.

34. Yki-Jarvinen H, Sammalkorpi K, Koivisto VA, Nikkila EA. 52. Sastrowijoto SH, van der Velden U, van Steenbergen TJM Severity, duration and mechanism of insulin resistance et al. Improved metabolic control, clinical periodontal during acute infections. J Clin Endocrinol Metab status and subgingival microbiology in insulin-dependent 1989;69:317-323. diabetes mellitus. A prospective study. J Clin Periodontol

35. AAP Position Paper: Diabetes and Periodontal Diseases. J 1990;17:233-242.

Periodontol 2000;71:664-678. 53. Stewart JE, Pager KA, Friedlander AH, Zadeh HH. The

36. Flegal KM, Carroll MD, Odgen CL, Johnson CL. Prevalence effect of periodontal treatment on glycemic control in and trends in obesity among U.S. adults 1999-2000. JAMA patients with type 2 diabetes mellitus. J Clin Periodontol 2002;288:1723-1727. 2001;28:306-310.

37. Kopelman PG. Obesity as a medical problem. Nature 54. Kiran M, Arpak N, Unsal E, Erdogan MF. The effect of 2000;404:635-643. improved periodontal health on metabolic control in type 2

38. Nishimura F, Iwatomo Y, Mineshiba J, et al. Periodontal diabetes mellitus. J Clin Periodontol 2005;32:266-272.
disease and diabetes mellitus: the role of tumor necrosis 55. Aldridge JP, Lester V, Watts TLP, Collins A, Viberti G,
factor-alpha in a 2-way relationship. J Periodontol Wilson RF. Single-blind studies of the effects of improved
2003;74:97-102. periodontal health on metabolic control of type 1 diabetes
39. Kanety H, Feinstein R, Papa MZ, et al. Tumor necrosis mellitus. J Clin Periodontol 1995;22:271-275.
factor alpha-induced phosphorylation of insulin receptor 56. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel
substrate (IRS- 1). Possible mechanism of suppression of S. Healing response to non-surgical periodontal therapy in
insulin-stimulated tyrosine phosphorylation of IRS- 1. J Biol patients with diabetes mellitus: clinical, microbiological,
Chem 1995;270:23780-23784. and immunological results. J Clin Periodontol 1998;25:112-
40. Bergman RN, Ader M. Free fatty acids and pathogenesis 124.
of type 2 diabetes mellitus. Trends Endocrinol Metab 57. Miller LS, Manwell MA, Newbold D, et al. The relationship
2000;11:351-356. between reduction in periodontal inflammation and
41. Saydah SH, Chandra A, Eberhardt MS. Pregnancy diabetes control: A report of 9 cases. J Periodontol
experience among women with and without gestational 1992;64:843-848.
diabetes in the U.S.: 1995 national survey of family growth. 58. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins
Diabetes Care 2005;28:1035-1040. D, Genco RJ. Response to periodontal therapy in diabetics
42. The Metabolic Syndrome. Available at http://www.diabetes.an d smokers. The relation of periodontal infections to
org/weightloss-and-exercise/weight loss/metabolicsyndrome. systemic diseases. J Periodontol 1996;67:1094-1102.
jsp.Accessed January26,2005. 59. Grossi SG, Skrepcinski FB, DeCaro T, et al. Treatment
43. Saely CH, Aczel S, Marte T, Langer P, Hoefle G, Drexel H. The of periodontal disease in diabetics reduces glycated
metabolic syndrome, insulin resistance, and cardiovascular hemoglobin. J Periodontol 1997;68:713-719.